Valk N K, vd Lely A J, de Herder W W, Lindemans J, Lamberts S W
Department of Medicine, Erasmus University, Rotterdam, The Netherlands.
J Clin Endocrinol Metab. 1994 Oct;79(4):1070-6. doi: 10.1210/jcem.79.4.7525625.
The early effects of human GH administration in GH-deficient (GHD) adults on protein, electrolyte homeostasis, and body composition were investigated in a metabolic ward study. Four patients were studied. In addition to a constant caloric and nitrogen (N)-sufficient diet, the patients received GH for 15 days in dosages of 12.5-25 micrograms/kg.day, with a maximum of 1.48 mg (4 IU)/day. GH replacement therapy was well tolerated by all patients. There was a slowly increasing effect on IGF-I levels, which reached a maximum after 8-12 days. The lowered IGFBP-3 levels normalized quicker, reaching maximum circulating concentrations 3 days after the start of GH treatment. Insulin concentrations maximally increased after 5 days, after which they leveled off. Insulin-like growth factor-binding protein-1 levels were maximally suppressed after 2 days of treatment. N balance became positive in all patients (mean, +2.8 +/- 0.2 g/day). Maximal N retention occurred after 2-5 days of GH administration, after which adaptation occurred. This degree of N retention represents a formation of 20 g muscle/day, which would mean an increase of 3.6 kg muscle over a period of 6 months of GH replacement therapy. A rapidly occurring positive sodium balance was observed within 24-72 h. Maximal sodium retention amounted to 61 mmol/day. It slowly decreased spontaneously over the subsequent 12 days. In parallel, rapid changes in bioelectrical impedance analysis (BIA) were observed. There was a close parallel between the net cumulative sodium retention and the decrease in BIA in these patients during the first 15 days of GH therapy. This suggests that the calculation of body composition compartments on the basis of BIA measurements during the initial phase of GH replacement does not represent actual changes in fat mass. This was substantiated with measurements of body composition using dual energy x-ray absorptiometry. In conclusion, measurements of early metabolic changes in GHD adults during the first 15 days after the start of GH replacement indicate that IGF-I values reach maximal levels only after 8-12 days, that the measurements of changes in IGFBP-1 and IGFBP-3 levels probably do not contribute to a determination of the optimal GH replacement dose, that maximal N-retaining effects occur within 2-5 days, after which adaptation occurs, that massive sodium retention occurs during this period, which spontaneously levels off, and that cumulative sodium retention closely correlates during this period with changes in BIA.(ABSTRACT TRUNCATED AT 400 WORDS)
在一项代谢病房研究中,调查了人生长激素(GH)对生长激素缺乏(GHD)成年患者蛋白质、电解质稳态及身体成分的早期影响。研究了4例患者。除了给予恒定的热量充足和氮(N)充足饮食外,患者接受15天的GH治疗,剂量为12.5 - 25微克/千克·天,最大剂量为1.48毫克(4国际单位)/天。所有患者对GH替代治疗耐受性良好。对胰岛素样生长因子-I(IGF-I)水平有缓慢增加的作用,在8 - 12天后达到最大值。降低的胰岛素样生长因子结合蛋白-3(IGFBP-3)水平恢复正常更快,在GH治疗开始后3天达到最大循环浓度。胰岛素浓度在5天后最大程度升高,之后趋于平稳。胰岛素样生长因子结合蛋白-1(IGFBP-1)水平在治疗2天后最大程度受到抑制。所有患者的氮平衡变为正值(平均,+2.8±0.2克/天)。最大氮潴留发生在GH给药2 - 5天后,之后出现适应。这种程度的氮潴留相当于每天形成20克肌肉,这意味着在6个月的GH替代治疗期间肌肉增加3.6千克。在24 - 72小时内观察到迅速出现的正钠平衡。最大钠潴留量达61毫摩尔/天。在随后的12天内它自发缓慢下降。同时,观察到生物电阻抗分析(BIA)的快速变化。在GH治疗的前15天,这些患者的净累积钠潴留与BIA降低之间存在密切平行关系。这表明在GH替代治疗初始阶段基于BIA测量计算身体成分分区并不代表脂肪量的实际变化。这通过使用双能X线吸收法测量身体成分得到证实。总之,在GH替代治疗开始后的前15天对GHD成年患者早期代谢变化的测量表明,IGF-I值仅在8 - 12天后达到最大水平,IGFBP-1和IGFBP-3水平变化的测量可能无助于确定最佳GH替代剂量,最大氮潴留作用在2 - 5天内出现,之后出现适应,在此期间发生大量钠潴留,其自发趋于平稳,并且在此期间累积钠潴留与BIA变化密切相关。(摘要截于400字)